20098-14-0
Chemical Structure
Idramantone
Synonym(s): Kemantane; 5-Hydroxy-2-adamantanone
- CAS No.: 20098-14-0
- Formula:C10H14O2
- Molecular Weight:166.22
IUPAC Name: 5-hydroxyadamantan-2-one
InChIKey: TZBDEVBNMSLVKT-UHFFFAOYSA-N
SMILES: O=C1C(C2)CC3CC2(O)CC1C3
Biological Activity: Idramantone (Kemantane, 5-Hydroxy-2-adamantanone) is an Adamantane derivative. Idramantone is an immunostimulant. Idramantone is a versatile starting material for the synthesis of various adamantine deivatives. Idramantone can be produced using P450cam monooxygenase coupled with NADH regeneration as an oxidation biocatalyst. Idramantone can be studied in research on bronchial pathology[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Idramantone | 98.0% | Idramantone (Kemantane, 5-Hydroxy-2-adamantanone) is an Adamantane derivative. Idramantone is an immunostimulant. Idramantone is a versatile starting material for the synthesis of various adamantine deivatives. Idramantone can be produced using P450cam monooxygenase coupled with NADH regeneration as an oxidation biocatalyst. Idramantone can be studied in research on bronchial pathology. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Boĭko SS, et al. Mezhvidovye razlichiia farmakokinetiki kemantana [Interspecific differences in kemantan pharmacokinetics]. Eksp Klin Farmakol. 1994;57(6):48-50. [Content Brief]
- [2]. Boĭko SS, et al., The clinical pharmacokinetics of kemantane. Farmakologiia i Toksikologiia, 01 Jan 1991, 54(1):57-59.
- [3]. Toshiki Furuya, et al., Biocatalytic production of 5-hydroxy-2-adamantanone by P450cam coupled with NADH regeneration, Journal of Molecular Catalysis B: Enzymatic, 2013, 94:111-118.
Keywords
